Role of magnesium in cardiac tachyarrhythmias.
The efficacy of magnesium therapy in patients with ventricular tachycardia has previously been reported. Recently completed and ongoing studies validate earlier observations that potassium and magnesium supplementation may control other cardiac arrhythmias, particularly in hypomagnesemic patients. Magnesium treatment is a viable therapeutic option when other antiarrhythmic agents fail to suppress ventricular tachycardia, ventricular fibrillation, multifocal atrial tachycardia, atrial fibrillation and supraventricular tachycardia.
Iseri
L T
LT
University of California, Irvine.
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000503:physiopathology; D004077:Digoxin / Q000009:adverse effects; D005260:Female; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008275:Magnesium Deficiency / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology
D004077:Digoxin; D008274:Magnesium